In this issue:
Challenges in IBD management in Australia
AGA CPG: Biomarkers for CD
BSG guidelines on sedation in GI endoscopy
ASGE CPG: Role of ergonomics for prevention of ERI
Triple combination therapy improves remission in CD
Patients with higher VAT may benefit from higher infliximab concentrations
Guselkumab in patients with moderate-to-severe UC
Upadacitinib approved for severe CD
Changes to the prescriber’s declaration section on application forms
PBS Safety Net early supply for 60- day prescriptions
Newly launched Australian IBD whitepaper
EEN treatment potential for adults with IBD
COVID-19 resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)